P. Haefelfinger

477 total citations
28 papers, 375 citations indexed

About

P. Haefelfinger is a scholar working on Spectroscopy, Pharmacology and Analytical Chemistry. According to data from OpenAlex, P. Haefelfinger has authored 28 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Spectroscopy, 9 papers in Pharmacology and 9 papers in Analytical Chemistry. Recurrent topics in P. Haefelfinger's work include Analytical Chemistry and Chromatography (9 papers), Analytical Methods in Pharmaceuticals (9 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). P. Haefelfinger is often cited by papers focused on Analytical Chemistry and Chromatography (9 papers), Analytical Methods in Pharmaceuticals (9 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). P. Haefelfinger collaborates with scholars based in Switzerland, United Kingdom and Austria. P. Haefelfinger's co-authors include J Raaflaub, D Hartmann, R. Amrein, Geoffrey T. Tucker, Michael Wall, A. Korn, T. W. Guentert, P. Heizmann, M. Komjati and J. A. Barrie and has published in prestigious journals such as Journal of Chromatography A, Cellular and Molecular Life Sciences and Acta Psychiatrica Scandinavica.

In The Last Decade

P. Haefelfinger

27 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Haefelfinger Switzerland 10 135 120 114 41 37 28 375
V. Ascalone Italy 14 182 1.3× 116 1.0× 151 1.3× 27 0.7× 38 1.0× 30 397
Martin R. Hackman United States 12 186 1.4× 132 1.1× 119 1.0× 46 1.1× 40 1.1× 16 518
S. K. Wahba Khalil United States 14 134 1.0× 126 1.1× 150 1.3× 19 0.5× 56 1.5× 32 425
J.P. Dubois Switzerland 12 88 0.7× 113 0.9× 100 0.9× 82 2.0× 66 1.8× 24 383
R.R. Brodie United States 15 84 0.6× 110 0.9× 135 1.2× 27 0.7× 66 1.8× 42 570
F L Vandemark United States 12 83 0.6× 191 1.6× 121 1.1× 69 1.7× 86 2.3× 12 437
J. Brès France 13 157 1.2× 48 0.4× 111 1.0× 38 0.9× 81 2.2× 23 455
A. C. Mehta United Kingdom 14 70 0.5× 156 1.3× 124 1.1× 19 0.5× 40 1.1× 40 443
Darioush Dadgar Ireland 11 83 0.6× 148 1.2× 193 1.7× 18 0.4× 54 1.5× 24 444
F. Demotes‐Mainard France 13 180 1.3× 59 0.5× 54 0.5× 35 0.9× 36 1.0× 41 383

Countries citing papers authored by P. Haefelfinger

Since Specialization
Citations

This map shows the geographic impact of P. Haefelfinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Haefelfinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Haefelfinger more than expected).

Fields of papers citing papers by P. Haefelfinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Haefelfinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Haefelfinger. The network helps show where P. Haefelfinger may publish in the future.

Co-authorship network of co-authors of P. Haefelfinger

This figure shows the co-authorship network connecting the top 25 collaborators of P. Haefelfinger. A scholar is included among the top collaborators of P. Haefelfinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Haefelfinger. P. Haefelfinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guentert, T. W., et al.. (1990). Pharmacokinetics of moclobemide after single and multiple oral dosing with 150 milligrams 3 times daily for 15 days. Acta Psychiatrica Scandinavica. 82(S360). 91–93. 27 indexed citations
2.
Hartmann, D, et al.. (1990). Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide.. British Journal of Clinical Pharmacology. 30(2). 245–252. 5 indexed citations
3.
Haefelfinger, P., et al.. (1984). Determination of the imidazo quinazoline derivative Ro 13-6438 in biological fluids by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 305(1). 153–161. 1 indexed citations
4.
Raaflaub, J, et al.. (1984). Single-dose pharmacokinetics of the MAO-inhibitor moclobemide in man.. PubMed. 34(1). 80–2. 26 indexed citations
5.
Haefelfinger, P.. (1982). Sensitive assay for the tricyclic antidepressant Ro 11-2465 in biological fluids by high-performance liquid chromatography and fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 233(1). 269–278. 5 indexed citations
6.
Haefelfinger, P. & Michael Wall. (1981). Ermittlung der Vergleichbarkeit einer Analysenmethode im Falle der Bestimmung von Medikamenten in Plasma. Fresenius Zeitschrift für Analytische Chemie. 307(4). 271–276. 9 indexed citations
7.
Haefelfinger, P.. (1981). Limits of the internal standard technique in chromatography. Journal of Chromatography A. 218. 73–81. 84 indexed citations
8.
Heizmann, P. & P. Haefelfinger. (1981). Studies on the specificity of the colorimetric assay for sulfamethoxazole. Cellular and Molecular Life Sciences. 37(8). 806–807. 2 indexed citations
9.
Haefelfinger, P.. (1980). Determination of bufuralol and its major metabolites in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 221(2). 327–335. 14 indexed citations
10.
Amrein, R., et al.. (1980). Pharmacokinetic and clinical observations on prolonged administration of flunitrazepam. European Journal of Clinical Pharmacology. 17(3). 189–196. 29 indexed citations
11.
Haefelfinger, P., et al.. (1980). Rückstandsbestimmungen des Antibioticums Myxin und seines Hauptmetaboliten nach intramammärer Infusion von Cuprimyxin bei Kühen. Fresenius Zeitschrift für Analytische Chemie. 302(2). 121–126. 1 indexed citations
12.
Haefelfinger, P.. (1979). A Novel Procedure for the Determination of Tricyclic Antidepressants in Plasma by Use of High Performance Liquid Chromatography. Journal of Chromatographic Science. 17(6). 345–349. 2 indexed citations
13.
Haefelfinger, P.. (1979). Determination of the 7‐amino‐metabolites of the 7‐nitro‐benzodiazepines in human plasma by thin‐layer chromatography. Journal of High Resolution Chromatography. 2(1). 39–42. 3 indexed citations
14.
Haefelfinger, P.. (1976). Determination of nanogram amounts of aromatic compounds by spectrophotometry on thin-layer chromatograms. Journal of Chromatography A. 124(2). 351–358. 21 indexed citations
15.
Haefelfinger, P., et al.. (1972). Colorimetrische Bestimmung von Panthenol und Pantothenaten. Analytical and Bioanalytical Chemistry. 262(3). 189–192. 4 indexed citations
16.
Haefelfinger, P.. (1970). Empfindlicher nachweis von substanzen mit primären aminogruppen auf dünnschichtplatten. Journal of Chromatography A. 48(1). 184–190. 7 indexed citations
17.
Haefelfinger, P.. (1968). Quantitative bestimmung eines quaternären alkaloides nach der dünnschichtchromatographischen trennung. Journal of Chromatography A. 33(2). 370–377.
18.
Studer, Patrick & P. Haefelfinger. (1968). Dünnschichtchromatographische bestimmung von meso-inosit auf fertigplatten. Journal of Chromatography A. 33(2). 385–390. 2 indexed citations
19.
Haefelfinger, P., et al.. (1964). Quantitative Bestimmung von Phenacetin, Isopropylantipyrin, Coffein und Persedon® in einem pharmazeutischen Kombinationspräparat). Archiv der Pharmazie. 297(11). 641–648. 7 indexed citations
20.
Barrer, R. M., J. A. Barrie, Jonathan M. Slater, et al.. (1957). Informal discussion, 9th May, 1957, on diffusion with special reference to high polymers. Transactions of the Faraday Society. 53(0). 1145–1150. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Ascalone Breakdown of academic impact, for papers by Martin R. Hackman Breakdown of academic impact, for papers by S. K. Wahba Khalil Breakdown of academic impact, for papers by J.P. Dubois Breakdown of academic impact, for papers by R.R. Brodie Breakdown of academic impact, for papers by F L Vandemark Breakdown of academic impact, for papers by J. Brès Breakdown of academic impact, for papers by A. C. Mehta Breakdown of academic impact, for papers by Darioush Dadgar Breakdown of academic impact, for papers by F. Demotes‐Mainard
Rankless by CCL
2026